Atrium Therapeutics, Inc. (RNA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 252.43M |
| Enterprise Value | -13.9M |
| P/E Ratio | -2.69 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 7.54 |
| Price/Book Ratio | 0.83 |
| Enterprise/Revenue | 4.52 |
| Enterprise/EBITDA | -1.12 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -3.97 |
| Operating Margin | -4.1 |
| Return On Assets | -0.33 |
| Return On Equity | -0.43 |
| Revenue | 18.62M |
| Revenue/Share | 1.37 |
| Gross Profit | 18.62M |
| EBITDA | -76.5M |
| Net Income | -76.68M |
| Diluted EPS | -4.48 |
| Total Cash | 264.21M |
| Total Cash/Share | 15.45 |
| Total Debt | 1.68M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 8.73 |
| Book Value Per Share | 12.54 |
| 52-Week Change | -29.76 |
| 52-Week High | 16.77 |
| 52-Week Low | 10 |
| Moving Average 50 Days | 12.56 |
| Moving Average 200 Days | 13.04 |
| Average Volume | 217,541 |
| Shares Outstanding | 17.11M |
| % Held by Institutions | 84.59 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |